OUR SCIENCE

Publications & Presentations

Saniona Icon blue

Publications & Presentations

September 5–9, 2020

A Randomized-Controlled Trial of Tesomet Resulted in Significant Weight Loss in Hypopituitary Patients with Hypothalamic Obesity

Huynh K, Klose M, Krogsgaar K, Drejer J, Byberg S, Madsbad S, Magkos F, Aharaz A, Edsberg B, Astrup A, Feldt-Rasmussen U. Endocrine Abstracts (2020)  70 AEP1073 | DOI: 10.1530/endoabs.70.AEP1073

April 19, 2020

Anti-Tremor Action of Subtype Selective Positive Allosteric Modulators of GABAA Receptors in a Rat Model of Essential Tremors

Amrutkar DV, Dyhring T, Jacobsen TA, Larsen JS, Sandager-Nielsen K. Cerebellum. 2020 Apr;19(2):265-274. doi: 10.1007/s12311-020-01106-w.PMID: 31989440

January 06, 2020

Pharmacology of Small- and Intermediate-Conductance Calcium-Activated Potassium Channels

Brown BM, Shim H, Christophersen P, Wulff H. Annu Rev Pharmacol Toxicol. 2020 Jan 6;60:219-240. doi: 10.1146/annurev-pharmtox-010919-023420. Epub 2019 Jul 23.PMID: 31337271

2019

Tesomet – A New Treatment Opportunity in Prader-Willi Syndrome. Results from Phase 2a Exploratory Studies in Adult and Adolescent Patients

Torok D, Kolouskova S, Walter P, Edsberg B, Dvorak R. International Prader-Willi Syndrome Organization Conference 2019. Abstract on page 47.

November 05, 2012

Anti‐Hypertensive Treatment Preserves Appetite Suppression while Preventing Cardiovascular Adverse Effects of Tesofensine in Rats

Hjorth Bentzen B, Grunnet M, Hyveled‐Nielsen L, Sundgreen C, Buus Lassen J, Hansen H. Obesity. 2012 Nov 5. https://doi.org/10.1002/oby.20122